AtriCure, Inc. (ATRC)
56.37
+1.23
(+2.23%)
USD |
NASDAQ |
Oct 05, 16:00
56.37
0.00 (0.00%)
After-Hours: 20:00
AtriCure Price : 56.37 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 52.51 | 55.25 | 52.00 | 55.14 | 1.616M |
| Oct 01, 2026 | 56.52 | 56.99 | 52.60 | 53.59 | 1.971M |
| Sep 30, 2026 | 58.01 | 58.60 | 56.15 | 56.20 | 1.111M |
| Sep 29, 2026 | 58.58 | 59.05 | 56.58 | 58.05 | 876278.0 |
| Sep 28, 2026 | 57.56 | 58.49 | 56.90 | 58.41 | 1.162M |
| Sep 25, 2026 | 60.85 | 61.32 | 57.89 | 58.38 | 1.592M |
| Sep 24, 2026 | 59.63 | 61.70 | 59.13 | 60.77 | 1.305M |
| Sep 23, 2026 | 58.92 | 61.48 | 58.72 | 59.96 | 1.206M |
| Sep 22, 2026 | 58.62 | 59.69 | 57.94 | 58.83 | 872574.0 |
| Sep 21, 2026 | 58.23 | 59.10 | 56.97 | 58.32 | 1.040M |
| Sep 18, 2026 | 58.51 | 59.88 | 57.98 | 58.10 | 8.670M |
| Sep 17, 2026 | 57.96 | 59.59 | 57.31 | 59.12 | 1.540M |
| Sep 16, 2026 | 55.66 | 57.25 | 55.66 | 57.14 | 1.217M |
| Sep 15, 2026 | 56.00 | 56.78 | 54.65 | 56.22 | 1.432M |
| Sep 14, 2026 | 54.84 | 56.02 | 54.81 | 55.79 | 1.155M |
| Sep 11, 2026 | 53.53 | 55.16 | 53.52 | 54.54 | 1.099M |
| Sep 10, 2026 | 52.31 | 53.66 | 51.86 | 52.96 | 961948.0 |
| Sep 09, 2026 | 53.16 | 53.70 | 51.96 | 53.03 | 1.659M |
| Sep 08, 2026 | 54.31 | 55.72 | 51.74 | 53.73 | 1.880M |
| Sep 04, 2026 | 52.03 | 52.53 | 51.03 | 51.52 | 714570.0 |
| Sep 03, 2026 | 52.88 | 53.50 | 51.19 | 52.46 | 1.169M |
| Sep 02, 2026 | 49.76 | 52.69 | 49.54 | 52.59 | 1.263M |
| Sep 01, 2026 | 48.43 | 49.25 | 47.54 | 48.92 | 718137.0 |
| Aug 31, 2026 | 48.23 | 48.84 | 46.61 | 48.35 | 529117.0 |
| Aug 28, 2026 | 49.32 | 49.98 | 48.35 | 48.54 | 390633.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Abbott Laboratories | 100.13 |
| Boston Scientific Corp. | 42.39 |
| AngioDynamics, Inc. | 15.55 |
| Alphatec Holdings, Inc. | 10.71 |
| Baxter International, Inc. | 24.22 |
Price Related Metrics
| PE Ratio | 260.49 |
| PS Ratio | 4.794 |
| Price to Book Value | 5.552 |
| Price to Free Cash Flow | 51.42 |
| Earnings Yield | 0.38% |
| Market Cap | 2.867B |
| Operating PE Ratio | 196.62 |
| Normalized PE Ratio | 243.92 |